Literature DB >> 10350022

Preparation and characterization of carmustine loaded polyanhydride wafers for treating brain tumors.

A J Domb1, Z H Israel, O Elmalak, D Teomim, A Bentolila.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 10350022     DOI： 10.1023/a:1011995728760

Source DB:  PubMed          Journal:  Pharm Res        ISSN： 0724-8741            Impact factor:   4.200


× No keyword cloud information.
  13 in total

1.  Pharmacokinetics of interstitial delivery of carmustine, 4-hydroperoxycyclophosphamide, and paclitaxel from a biodegradable polymer implant in the monkey brain.

Authors:  L K Fung; M G Ewend; A Sills; E P Sipos; R Thompson; M Watts; O M Colvin; H Brem; W M Saltzman
Journal:  Cancer Res       Date:  1998-02-15       Impact factor: 12.701

2.  Optimizing interstitial delivery of BCNU from controlled release polymers for the treatment of brain tumors.

Authors:  E P Sipos; B Tyler; S Piantadosi; P C Burger; H Brem
Journal:  Cancer Chemother Pharmacol       Date:  1997       Impact factor: 3.333

3.  Morphological characterization of polyanhydride biodegradable implant gliadel during in vitro and in vivo erosion using scanning electron microscopy.

Authors:  W Dang; T Daviau; H Brem
Journal:  Pharm Res       Date:  1996-05       Impact factor: 4.200

4.  Erosion of a new family of biodegradable polyanhydrides.

Authors:  L Shieh; J Tamada; I Chen; J Pang; A Domb; R Langer
Journal:  J Biomed Mater Res       Date:  1994-12

5.  The intracerebral distribution of BCNU delivered by surgically implanted biodegradable polymers.

Authors:  S A Grossman; C Reinhard; O M Colvin; M Chasin; R Brundrett; R J Tamargo; H Brem
Journal:  J Neurosurg       Date:  1992-04       Impact factor: 5.115

6.  Interstitial chemotherapy of the 9L gliosarcoma: controlled release polymers for drug delivery in the brain.

Authors:  R J Tamargo; J S Myseros; J I Epstein; M B Yang; M Chasin; H Brem
Journal:  Cancer Res       Date:  1993-01-15       Impact factor: 12.701

7.  Biodegradable polymers for controlled delivery of chemotherapy with and without radiation therapy in the monkey brain.

Authors:  H Brem; R J Tamargo; A Olivi; M Pinn; J D Weingart; M Wharam; J I Epstein
Journal:  J Neurosurg       Date:  1994-02       Impact factor: 5.115

8.  Molecular weight changes in polymer erosion.

Authors:  A D'Emanuele; J Hill; J A Tamada; A J Domb; R Langer
Journal:  Pharm Res       Date:  1992-10       Impact factor: 4.200

9.  Interstitial taxol delivered from a biodegradable polymer implant against experimental malignant glioma.

Authors:  K A Walter; M A Cahan; A Gur; B Tyler; J Hilton; O M Colvin; P C Burger; A Domb; H Brem
Journal:  Cancer Res       Date:  1994-04-15       Impact factor: 12.701

10.  Effectiveness of controlled release of a cyclophosphamide derivative with polymers against rat gliomas.

Authors:  K D Judy; A Olivi; K G Buahin; A Domb; J I Epstein; O M Colvin; H Brem
Journal:  J Neurosurg       Date:  1995-03       Impact factor: 5.115
View more
  11 in total

1.  Mathematical Modelling of Convection Enhanced Delivery of Carmustine and Paclitaxel for Brain Tumour Therapy.

Authors:  Wenbo Zhan; Davis Yohanes Arifin; Timothy Ky Lee; Chi-Hwa Wang
Journal:  Pharm Res       Date:  2017-02-02       Impact factor: 4.200

2.  Development of Poly Unsaturated Fatty Acid Derivatives of Aspirin for Inhibition of Platelet Function.

Authors:  Jahnabi Roy; Reheman Adili; Richard Kulmacz; Michael Holinstat; Aditi Das
Journal:  J Pharmacol Exp Ther       Date:  2016-08-03       Impact factor: 4.030

Review 3.  Advanced drug delivery systems of curcumin for cancer chemoprevention.

Authors:  Shyam S Bansal; Mehak Goel; Farrukh Aqil; Manicka V Vadhanam; Ramesh C Gupta
Journal:  Cancer Prev Res (Phila)       Date:  2011-05-05

4.  Electrospun micro- and nanofibers for sustained delivery of paclitaxel to treat C6 glioma in vitro.

Authors:  Jingwei Xie; Chi-Hwa Wang
Journal:  Pharm Res       Date:  2006-08       Impact factor: 4.200

5.  Characterization and in vitro degradation of poly(octadecanoic anhydride).

Authors:  An-Jie Dong; Jin-Wei Zhang; Kai Jiang; Lian-Dong Deng
Journal:  J Mater Sci Mater Med       Date:  2007-06-19       Impact factor: 3.896

6.  Anhydride prodrug of ibuprofen and acrylic polymers.

Authors:  Boaz Mizrahi; Abraham J Domb
Journal:  AAPS PharmSciTech       Date:  2009-04-21       Impact factor: 3.246

Review 7.  Pharmacokinetics of the carmustine implant.

Authors:  Alison B Fleming; W Mark Saltzman
Journal:  Clin Pharmacokinet       Date:  2002       Impact factor: 6.447

8.  Anhydride prodrugs for nonsteroidal anti-inflammatory drugs.

Authors:  Osnat Shaaya; Amir Magora; Tzviel Sheskin; Neeraj Kumar; Abraham J Domb
Journal:  Pharm Res       Date:  2003-02       Impact factor: 4.200

9.  Self-assembly of cytotoxic peptide amphiphiles into supramolecular membranes for cancer therapy.

Authors:  R Helen Zha; Shantanu Sur; Samuel I Stupp
Journal:  Adv Healthc Mater       Date:  2012-07-31       Impact factor: 9.933

10.  Polifeprosan 20, 3.85% carmustine slow-release wafer in malignant glioma: evidence for role in era of standard adjuvant temozolomide.

Authors:  Lawrence Kleinberg
Journal:  Core Evid       Date:  2012-10-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.